Intraductal breast neoplasm

Summary

Intraductal breast neoplasm (MONDO:0002488) is a cancer. A subtype of breast neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	intraductal breast neoplasm
Mondo ID	MONDO:0002488
DOID	DOID:3013
NCIT	C36083
UMLS	C0948967
MedGen	184927
Is cancer (heuristic)	yes

Also known as: intraductal breast neoplasm

Disease family

This is a subtype of breast neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › breast disorder › breast neoplasm › intraductal breast neoplasm

Related subtypes (10): breast benign neoplasm, nipple neoplasm, breast myoepithelial tumor, breast neuroendocrine neoplasm, breast granular cell tumor, breast hemangiopericytoma, breast fibrosis, breast cancer, benign ductal tumor of breast, breast fibroepithelial neoplasm

Subtypes (2): intraductal papillary breast neoplasm, breast intraductal proliferative lesion

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.